TY  - GEN
AU  - García-Aranda, Marilina
AU  - Redondo, Maximino
PY  - 2019
DO  - 10.3390/ijms20092296
UR  - http://hdl.handle.net/20.500.12105/17863
AB  - The interaction between programmed cell death protein (PD-1) and its ligand (PD-L1) is one of the main pathways used by some tumors to escape the immune response. In recent years, immunotherapies based on the use of antibodies against PD-1/PD-L1 have...
LA  - eng
KW  - MHC
KW  - Cancer
KW  - Checkpoint blockade
KW  - Immunotherapy
KW  - Inhibitor
KW  - Kinase
KW  - Resistance
KW  - Tumor escape
KW  - B7-H1 Antigen
KW  - Biomarkers, Tumor
KW  - Humans
KW  - Immunotherapy
KW  - Molecular Targeted Therapy
KW  - Programmed Cell Death 1 Receptor
KW  - Protein Kinases
TI  - Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy.
TY  - research article
ER  -